208 related articles for article (PubMed ID: 16611099)
41. [Hereditary hemorrhagic telangiectasia].
Pérez del Molino A; Zarrabeitia R; Fernández A
Med Clin (Barc); 2005 Apr; 124(15):583-7. PubMed ID: 15860174
[TBL] [Abstract][Full Text] [Related]
42. Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology.
Bofarid S; Hosman AE; Mager JJ; Snijder RJ; Post MC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801690
[TBL] [Abstract][Full Text] [Related]
43. Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia.
Shovlin CL
Clin Sci (Lond); 1998 Mar; 94(3):207-18. PubMed ID: 9616253
[TBL] [Abstract][Full Text] [Related]
44. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.
Best DH; Vaughn C; McDonald J; Damjanovich K; Runo JR; Chibuk JM; Bayrak-Toydemir P
J Med Genet; 2011 May; 48(5):358-60. PubMed ID: 21378382
[TBL] [Abstract][Full Text] [Related]
45. Genetic abnormalities in hereditary hemorrhagic telangiectasia.
Marchuk DA
Curr Opin Hematol; 1998 Sep; 5(5):332-8. PubMed ID: 9776212
[TBL] [Abstract][Full Text] [Related]
46. [Hereditary hemorrhagic telangiectasia].
Duffau P; Lazarro E; Viallard JF
Rev Med Interne; 2014 Jan; 35(1):21-7. PubMed ID: 23517771
[TBL] [Abstract][Full Text] [Related]
47. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.
Abdalla SA; Geisthoff UW; Bonneau D; Plauchu H; McDonald J; Kennedy S; Faughnan ME; Letarte M
J Med Genet; 2003 Jul; 40(7):494-502. PubMed ID: 12843319
[TBL] [Abstract][Full Text] [Related]
48. HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis.
Lux A; Müller R; Tulk M; Olivieri C; Zarrabeita R; Salonikios T; Wirnitzer B
Orphanet J Rare Dis; 2013 Jun; 8():94. PubMed ID: 23805858
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of molecular background of hereditary haemorrhagic telangiectasia--Rendu-Osler-Weber disease--preliminary results].
Kostrzewska-Poczekaj M; Wróbel M; Rydzanicz M; Szyfter W; Szyfter K
Otolaryngol Pol; 2008; 62(6):700-4. PubMed ID: 19205515
[TBL] [Abstract][Full Text] [Related]
50. [Hereditary hemorragic telangiectasia: the state of art].
Colotto M; Castellano V; Anatra GM; Borgia MC
Clin Ter; 2007; 158(3):253-60. PubMed ID: 17612287
[TBL] [Abstract][Full Text] [Related]
51. [Rendu-Osler disease: clinical and molecular update].
Bailly S; Dupuis-Girod S; Plauchu H
Med Sci (Paris); 2010 Oct; 26(10):855-60. PubMed ID: 20929677
[TBL] [Abstract][Full Text] [Related]
52. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
[TBL] [Abstract][Full Text] [Related]
53. Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia.
Ali BR; Ben-Rebeh I; John A; Akawi NA; Milhem RM; Al-Shehhi NA; Al-Ameri MM; Al-Shamisi SA; Al-Gazali L
PLoS One; 2011; 6(10):e26206. PubMed ID: 22022569
[TBL] [Abstract][Full Text] [Related]
54. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management.
Stuhrmann M; El-Harith el-HA
Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283
[TBL] [Abstract][Full Text] [Related]
55. High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients.
Schulte C; Geisthoff U; Lux A; Kupka S; Zenner HP; Blin N; Pfister M
Hum Mutat; 2005 Jun; 25(6):595. PubMed ID: 15880681
[TBL] [Abstract][Full Text] [Related]
56. Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia.
Ruiz-Llorente L; Chiapparino E; Plumitallo S; Danesino C; Bayrak-Toydemir P; Pagella F; Manfredi G; Bernabeu C; Jovine L; Olivieri C
Gene; 2019 May; 696():33-39. PubMed ID: 30763665
[TBL] [Abstract][Full Text] [Related]
57. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan.
Dakeishi M; Shioya T; Wada Y; Shindo T; Otaka K; Manabe M; Nozaki J; Inoue S; Koizumi A
Hum Mutat; 2002 Feb; 19(2):140-8. PubMed ID: 11793473
[TBL] [Abstract][Full Text] [Related]
58. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.
Ardelean DS; Letarte M
Front Genet; 2015; 6():35. PubMed ID: 25717337
[TBL] [Abstract][Full Text] [Related]
59. Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia.
Lee NP; Matevski D; Dumitru D; Piovesan B; Rushlow D; Gallie BL
J Med Genet; 2011 May; 48(5):353-7. PubMed ID: 21415079
[TBL] [Abstract][Full Text] [Related]
60. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
Azuma H
J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
